Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MTT for Adults with ASD and GI Disorders
NCT03408886Phase 2Active, not recruiting
- Sponsor
- Arizona State University
- Start
- Jan 2018
- Primary completion
- Apr 2022
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of CP101 in Autism Spectrum Disorder (ASD), gastrointestinal disorders, sponsored by Arizona State University. Started Jan 2018; status: active, not recruiting.
02
Drugs
CP101
03
Conditions
Autism Spectrum Disorder (ASD)gastrointestinal disorders
Beyond the preview
Go deeper on NCT03408886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03408886.